Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?

Like
Comment
Favorite

Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?

Simply Wall St.07-24 23:36

In July 2026, the Illinois Appellate Court upheld a US$45,000,000 jury verdict for the family of Theresa Garcia, confirming that asbestos-contaminated Johnson & Johnson talc-based baby powder caused ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2654933036?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/1820759186-main-header/1756203109122","is_english":true,"pubTime":"2026-07-24 23:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2654933036","market":"hk","top_or_hot":-1,"title":"Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?","media":"Simply Wall St.","content":"<div>\n<p>In July 2026, the Illinois Appellate Court upheld a US$45,000,000 jury verdict for the family of Theresa Garcia, confirming that asbestos-contaminated Johnson & Johnson talc-based baby powder caused ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/household/nyse-kvue/kenvue/news/does-illinois-talc-verdict-successor-liability-ruling-change\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoes Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-24 23:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/household/nyse-kvue/kenvue/news/does-illinois-talc-verdict-successor-liability-ruling-change><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In July 2026, the Illinois Appellate Court upheld a US$45,000,000 jury verdict for the family of Theresa Garcia, confirming that asbestos-contaminated Johnson & Johnson talc-based baby powder caused ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/household/nyse-kvue/kenvue/news/does-illinois-talc-verdict-successor-liability-ruling-change\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0320765646.SGD","symbol_name":"FTIF - Franklin Income A MDIS SGD-H1","start_time":0,"source_url":"https://simplywall.st/stocks/us/household/nyse-kvue/kenvue/news/does-illinois-talc-verdict-successor-liability-ruling-change","article_id":"2654933036","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/1820759186-main-header/1756203109122"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/household/nyse-kvue/kenvue/news/does-illinois-talc-verdict-successor-liability-ruling-change","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2654933036","pubTimestamp":1784907387,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In July 2026, the Illinois Appellate Court upheld a US$45,000,000 jury verdict for the family of Theresa Garcia, confirming that asbestos-contaminated Johnson & Johnson talc-based baby powder caused her mesothelioma and affirming all trial court rulings. \nThe court also confirmed that Kenvue and Johnson & Johnson Holdco (NA) Inc. can be held liable as successors to Johnson & Johnson’s former consumer products business, underscoring enduring legal exposure tied to legacy talc products. \nWe’ll...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","RSPS":"Invesco S&P 500 Equal Weight Consumer Staples ETF","SG9999002224.SGD":"Allianz Global High Payout SGD","JDOC":"JPMORGAN HEALTHCARE LEADERS ETF","IYH":"iShares U.S. Healthcare ETF","JNJ":"强生","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","IE00BDGV0183.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) INC","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","FHLC":"Fidelity MSCI Health Care Index","LU0210528500.USD":"JPM AMERICA EQUITY \"A\" ACC","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","LU0426417589.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) INC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","TRUH":"VanEck Healthcare TruSector ETF","BK4504":"桥水持仓","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","GDOC":"Goldman Sachs Future Health Care Equity ETF","VHT":"Vanguard Health Care ETF","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","KVUE":"Kenvue Inc","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","XLV":"健康照护类股ETF-SPDR","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU2750360641.GBP":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (GBPHDG) INC","LU1043141123.HKD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (HKD) INC 2","GLAM":"Corgi Beauty, Skincare & Aesthetics ETF","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","MEDX":"HORIZON KINETICS MEDICAL ETF","RXL":"ProShares Ultra Health Care","LU2213496289.HKD":"ALLIANZ INCOME AND GROWTH \"AT\" (HKD) ACC","IHE":"iShares U.S. Pharmaceuticals ETF","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","PJP":"INVESCO PHARMACEUTICALS ETF","IXJ":"全球医疗业ETF-iShares","LU1145028129.USD":"ALLIANZ INCOME AND GROWTH \"AQ\" (USD) INC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BMED":"iShares Health Innovation Active ETF","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","FTXH":"First Trust Nasdaq Pharmaceuticals ETF","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","NA":"纳比特","BK4533":"AQR资本管理(全球第二大对冲基金)"},"translate_title":"伊利诺伊州滑石粉裁决继承人责任裁决会改变 Kenvue (KVUE) 的牛市吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GLAM":0.6,"NA":1,"IYH":0.6,"BMED":0.6,"GDOC":0.6,"MEDX":0.6,"RXL":0.6,"VHT":0.6,"XLV":0.6,"PJP":0.6,"RSPS":0.6,"IXJ":0.6,"FHLC":0.6,"KVUE":1.5,"TRUH":0.6,"FTXH":0.6,"JNJ":0.83,"IHE":0.6,"JDOC":0.6},"content_text":"In July 2026, the Illinois Appellate Court upheld a US$45,000,000 jury verdict for the family of Theresa Garcia, confirming that asbestos-contaminated Johnson & Johnson talc-based baby powder caused her mesothelioma and affirming all trial court rulings.  The court also confirmed that Kenvue and Johnson & Johnson Holdco (NA) Inc. can be held liable as successors to Johnson & Johnson’s former consumer products business, underscoring enduring legal exposure tied to legacy talc products.  We’ll now examine how this affirmation of successor liability in a major asbestos case affects Kenvue’s existing investment narrative and perceived risks. Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.AdvertisementKenvue Investment Narrative RecapTo own Kenvue, you need to believe in the resilience of its everyday consumer brands and its ability to simplify operations while integrating Kimberly Clark. The Illinois talc verdict underlines that legacy legal exposure remains a meaningful overhang, but it does not obviously alter the near term focus on the Kimberly Clark merger and upcoming earnings. The most relevant recent announcement here is the Illinois Appellate Court’s confirmation that Kenvue can be held liable as a successor to Johnson & Johnson’s former consumer products business. This ruling sits alongside ongoing merger execution, leadership changes and margin pressures, and may influence how investors weigh legal contingencies against the expected benefits of combining with Kimberly Clark. Yet beneath the merger headlines, investors should also be aware of the enduring successor liability risk tied to... Read the full narrative on Kenvue (it's free!)Kenvue's narrative projects $16.7 billion revenue and $2.3 billion earnings by 2029. This requires 2.9% yearly revenue growth and a $0.7 billion earnings increase from $1.6 billion today.Uncover how Kenvue's forecasts yield a $19.50 fair value, a 3% upside to its current price.Exploring Other PerspectivesKVUE 1-Year Stock Price Chart Three fair value estimates from the Simply Wall St Community span roughly US$19.50 to US$32.22 per share, showing how far apart individual views can be. You should weigh those opinions against Kenvue’s ongoing legal exposure from legacy talc products, which could influence how the business converts brand strength into future performance.Explore 3 other fair value estimates on Kenvue - why the stock might be worth as much as 70% more than the current price!Reach Your Own ConclusionDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Kenvue research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.Our free Kenvue research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Kenvue's overall financial health at a glance.Looking For Alternative Opportunities?Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.The latest GPUs need a type of rare earth metal called Terbium and there are only 29 companies in the world exploring or producing it. Find the list for free.Find 38 companies with promising cash flow potential yet trading below their fair value.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Kenvue might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}